169 刘晓娜, 赵根明, 徐望红 200032 7 1 2 3 4 5 6 R181.3 A 1004-6194(2016)03-0169-06 Inspiration of typical cases in prevention and control of chronic non-communicable disease in China LIU Xiao-na, ZHAO Gen-ming, XU Wang-hong School of Public Health; Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai 200032, China Corresponding author: XU Wang-hong, E-mail: wanghong.xu@fudan.edu.cn Abstract: Objective To screen the typical cases in the prevention and control of chronic non-communicable diseases (NCDs) in China and to provide the experience for other developing countries. Methods A systemic review of literatures was conducted to collect research reports and publications related to NCDs prevention and control in China by searching Pubmed, Web of Science, Cochrane, CAJD, CBMdisc and other related websites. Results A total of 7 typical cases of NCDs prevention and control were selected and studied. The analysis of typical cases showed the characters and common regular patterns: (1) the leading role of the governments in NCDs prevention and control; (2) the cooperation of multiple departments; (3) strategies of combination of high risk population with general population; (4) the intervention located in communities and workplaces; (5) the reducing of exposure to main risk factors of NCDs; (6) the establishment of permanent guarantee for NCDs. Conclusion Chinese experience in NCDs prevention and control provides the reference for other developing countries. Key words: Chronic non-communicable disease; Prevention and control; Cases DOI 10.16386/j.cjpccd.issn.1004-6194.2016.03.003 Consulting service for center of excellence in Global Health Policy Development and Governance in China GHSP-CS-OP3-02 E-mail 14211020005@fudan.edu.cn E-mail: wanghong.xu@fudan.edu.cn 6. 25 J., 2013, 15,,,. 114 J. 19 33 : 108-109., 20 : 1884-1888. 2012, 20 7,,,. 16,,,. 23 J., 2005, 3 10: 177-178. J., 2 : 149-150. 2012, 15 8. 17,,,. 2013 J., 2013, 5 1 : 53-64. J., 12 : 1259-1261. 2013, 22 9. 18 Sebastiani G, Tempesta D, Fattovich G, et al. Prediction of oe - 2003 J., 2004, 21 3 : sophageal varices in hepatic cirrhosis by simple serum non-invasive 149-151. markers: results of a multicenter, large-scale study J. J Hepatol, 10,,. 2010, 53 4 : 630-638. J., 2012, 13 5 : 310-313. 19,,,. 11,,,. logistic J., 2012, 7 8 : 29-30, 56. J., 6 2012, : 649-651. 33 20,,,. 12,,,. J., 10 : 1075-1076, 2011, 27 1086. J., 5 : 442-444. 2013, 16 21,,,. 13,,,. J., 2014, 1 19: 24-27. J., 2012, 7 17: 460-464. 14,,,. 2014-11-18 2015-04-10 J., 2013, 18 8 : 507-509, 516.
170 [15-17] [18-20] [21-22] [23-26] 20 60 5 2.2 入选案例的设计和实施情况 1 2.2.1 1 1.1 案例纳入和排除标准 1 1960-2015 1986 33 2 110 660 577 IGT 3 438 4 5 138 1 2 1992 46.0% 1.2 文献检索方法 51% 2006 20 80% 93% 43% 3.6 [1-3] CAJD IGT CBMdisc IGT China [27-28] intervention prevention Pubmed Web of Science Cochrane NLM MEDLINE OLDMEDLINE [1, 29] 17 LOCATORplus MEDLINEplus DIRLINE HSRProj 2.2.2 Google 1974 workshop 2 626 312 7 2 2.1 入选案例 7 81987-1995 [1-6] [7-9] 2.5 2.2 mmhg [8] 14 [10-14] 1982-1983 1998 8
171 1 IGT 6 n=577 1986~1992 31% 46% 51% 23 41% 45% 8 n=2200 1987~1995 IGT. D β- E P 1 1 P 2 2 3.4 mmhg 2.5 mmhg 9 9, n=292948 1992~2000 49.5%, 16.0% 87.0% 9 n=12 1991~1999 18.7% 17.7% 40~ 1972~ 6.29% 4.19% 5.78% 3.74% P 1 P 6 P 1 9% n=3318 1985~1991 4% P 2 n=29584 P 2 5 1986~1991 P 2 D 7.3 n=3365 C 1995-2003 E 8 2.2.3 [9] 24 54.7% 74.3% [9] 1992-2000 3 2 1 2 35 3 2 1993 9 87% 49.5% 16.0% [11-12] 3
172 [21] 29 584 [22] 2.2.4 1991-1999 5 3 6.6 2 5.4 2.2.7 30 CAG IM DYS 9 1995-2003 NCI C 18.7% 17.7% [17] E 4 1999 7.3 2003 [24-25] [26] 2.2.5 1972 AFP 3 B 1 2 4 3.1 政府主导是慢性病防控的关键 [30-31] 2011 49.95/10 25.75/10 45.11/10 24.12/10 6.29% 4.19% 5.78% 3.74% 35~44 25~34 15~24 [32] 5 27 2.2.6 35 A 13%~20% C 23% 86%~90% [33] 3.2 多部门协调合作, 专家指导帮助是慢性病防控的 1982 重要保障 3 318
173 3 3.3 积极开展健康教育和健康促进, 着眼于主要危险 3.6 慢性病的防控要持之以恒, 注重长效机制的建因素的综合干预 立 6 20 20 60 80 90 3.4 高危人群和全人群策略并举, 降低慢性病疾病负 担 4 70 2009 35 65 3.5 全社会动员, 抓好社区和工作场所两块干预实施 的主要阵地 31 7 300 2006 860.4/10 732.9/10 2012
174 737.5/10 642.9/10 2006-2008 [34] 2009 17,,,. J., 2001, 23 5 :428-431. 18 Yu SY, Chu YJ, Li WG. Selenium chemoprevention of liver cancer in animals and possible human applications J. Biol Trace Elem Res, 1988, 15 1 :231-241. 19 Qu C, Chen T, Fan C, et al. Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30 -year follow -up of the Qidong Hepatitis B Intervention Study: a cluster randomized controlled trial J. PLoS Med, 2014,11 12 :e1001774. 20 Yu SY, Zhu YJ, Li WG, et al. A preliminary report on the intervention 1 Li G, Zhang P, Wang J, et al. The long -term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China J. Biol Trace Elem Res, 1991, Prevention Study: a 20-year follow-up study J. Lancet, 2008, 371 29 3 :289-294. 9626 : 1783-1789. 21 Li JY, Taylor PR, Li B, et al. Nutrition intervention trials in Linxian, 2 Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in China: multiple vitamin/mineral supplementation, cancer incidence, preventing NIDDM in people with impaired glucose tolerance. The Da and disease -specific mortality among adults with esophageal Qing IGT and Diabetes Study J. Diabetes Care, 1997,20 4 :537- dysplasia J. J Natl Cancer Inst, 1993,85 18 :1492-1498. 544. 22 Blot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in 3,,,. Linxian, China: supplementation with specific vitamin/mineral 20 J. combinations, cancer incidence, and disease-specific mortality in the, 2008, 10 47 :854-855. general population J. J Natl Cancer Inst, 1993,85 18 :1483-1492. 4 Pan XR, Hu YH, Li GW, et al. Impaired glucose tolerance and its 23 Pan KF, Zhang L, Gerhard M, et al. A large randomised controlled relationship to ECG-indicated coronary heart disease and risk factors intervention trial to prevent gastric cancer by eradication of among Chinese. Da Qing IGT and diabetes study J. Diabetes Care, Helicobacter pylori in Linqu County, China: baseline results and 1993, 16 1 :150-156. factors affecting the eradication J. Gut, 2016,65 1 :9-18. 5. 6 14 24. 23 20 J. J., 2006, 38 6 :565-570., 17 2008, :15-16. 23 25, Brown LM,,. 6. & C. 20 C. 2008, 2007., 28-29. 26,,,. 2008 10 7,. J. J., 39 :27-30. 2005, 85, 2003,37 2 :81-83. 27. J., 2008,5 8 : 8,,,. 375-377. J., 1 :22-25. 1999,27 28 Yang WY, Lu JM, Weng JP, et al. Prevalence of diabetes among men 9,,. 24 and women in China J. N Engl J Med, 2010, 362 12 :1090-1101. J., 2 :93-97. 2003,37 29 Li G, Zhang P, Wang J, et al. Cardiovascular mortality, all -cause 10,,,. mortality, and diabetes incidence after lifestyle intervention for people J., 2002,31 1 :12-16. with impaired glucose tolerance in the Da Qing Diabetes Prevention 11,,,. Study: a 23-year follow-up study J. Lancet Diabetes Endocrinol, J., 1 :30-2002,4 2014, 2 6 :474-480. 33. 30,,,. 12,,,. 9 J.,2014,34 11 :1052-1057. J., 2002,10 2 : 31. 15 J., 49-51. 2001,10 1 :3-7. 13,,,. 32. :1972-2011 M. J., 2002,6 15 :2204-2205, 2213.,2013:81-92. 14 Wang WZ, Jiang B, Wu SP, et al. Change in stroke incidence from a 33. J., 1995 S1 :128- population -based intervention trial in three urban communities in 129. China J. Neuroepidemiology, 2007,28 3 :155-161. 34 Astell-Burt T, Liu Y, Feng X, et al. Health reform and mortality in 15,. 1991-1999 China: multilevel time-series analysis of regional and socioeconomic J., 6 : 424-427. 2001, 22 inequities in a sample of 73 million J. Sci Rep,2015,5:15038. doi: 16,,,. 8 10.1038/srep15038. J., 2001, 23 1 :15-18. 2015-09-25 2015-11-13